NCT05562349View on ClinicalTrials.gov

Clavulanic Acid for the Treatment of Cocaine Use Disorder

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Cocaine Dependence
Interventions
DRUG

Clavulanic Acid Only Product

Drug will be given in 250mg capsules

DRUG

Placebo

Capsule with no active medication - identical to drug capsule

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

29403

MUSC, Charleston

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

Research Foundation for Mental Hygiene, Inc.

OTHER

lead

Temple University

OTHER